Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...

Among patients with type 2 diabetes, use of GLP-1 agonists may increase the risks for adhesive capsulitis and required ...

The Alabama Poison Information Center has seen a major increase in calls relating to GLP-1 medications. Ozempic, Mounjaro, ...

Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight loss drugs, but the jury's out on w ...

Share on Pinterest Women with diabetes may get the strongest cardiovascular protection from GLP-1 agonists. Image credit: Kathryn Gamble for The Washington Post via Getty Images. Diabetes ...

A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...

SGLT2 inhibitors and GLP-1 agonists also reduced the risk of major adverse cardiovascular events. Why age could affect diabetes drug efficacy “It is well established that all three medications ...

Companies such as Teladoc and Omada Health have embraced GLP-1s while dangling the prospect of lowered costs to their ...

The authors note that all nine patients were taking a GLP-1 because they were battling obesity and/or diabetes. So it's unclear if the vision troubles were linked to use of a GLP-1 or one of the ...

GLP-1 receptor agonists were more cardioprotective in younger people, but reduced HbA1c more with age. Sex didn't mediate efficacy for any agent. The age of type 2 diabetes patients may alter the ...

“Exenatide is a licensed and effective treatment for type 2 diabetes. It is a GLP-1 receptor agonist and stimulates insulin release in the presence of elevated blood glucose,” Nirosen ...